Who are Intra-Arterial Albumin's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intra-arterial-albumin.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-18 · How we verify

Intra-Arterial Albumin — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intra-Arterial Albumin (Intra-Arterial Albumin) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Plasma protein/colloid. Area: Critical Care / Organ Perfusion.

phase 3 Plasma protein/colloid Critical Care / Organ Perfusion Small molecule Live · refreshed every 30 min

Target snapshot

Intra-Arterial Albumin (Intra-Arterial Albumin) — Tianjin Huanhu Hospital. Intra-arterial albumin administration increases plasma oncotic pressure and improves microcirculation to enhance tissue perfusion and organ function.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Intra-Arterial Albumin TARGET	Intra-Arterial Albumin	Tianjin Huanhu Hospital	phase 3	Plasma protein/colloid

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Plasma protein/colloid class)

Tianjin Huanhu Hospital · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intra-Arterial Albumin — Competitive Intelligence Brief. https://druglandscape.com/ci/intra-arterial-albumin. Accessed 2026-05-18.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab